Skip to main content
Clinical Trials/NCT05571826
NCT05571826
Recruiting
Not Applicable

Effectiveness of Telerehabilitation Interventions in Persons With Multiple Sclerosis: Patient Perspective

Dokuz Eylul University1 site in 1 country30 target enrollmentOctober 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Dokuz Eylul University
Enrollment
30
Locations
1
Primary Endpoint
Telehealth Usability Questionnaire
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Multiple sclerosis (MS) is an inflammatory, demyelinating, neurodegenerative disease of the central nervous system of unknown etiology. The most common clinical signs and symptoms are motor dysfunction, fatigue, spasticity, impaired mobility, cognitive impairment, chronic pain, depression, decreased quality of life, and bladder and bowel dysfunction. 66% of people with MS have impaired upper extremity function. As a result of the deterioration in upper extremity function, the performance of many daily living activities affects performance. As a result of this influence, there is a decrease in the functional independence of people, quality of life, and participation in activities in the community. Exercise training represents an existing behavioral treatment approach to safely manage many functional, symptomatic, and quality-of-life outcomes in MS. Telerehabilitation has been defined as "the delivery of rehabilitation services through information and communication technologies." Telerehabilitation has proven to be useful for people with MS by increasing physical activity and reducing fatigue. In the studies, telerehabilitation and face-to-face rehabilitation services were compared, and stated that they had similar results. At the same time, it was stated that telerehabilitation provides people with gains in terms of time and cost. In addition to all these, the researchers emphasized the benefits they received from telerehabilitation from the people's statements. Therefore, the results of this study, which will be performed on MS patients, will enable the evaluation of telerehabilitation strategies from the patient's point of view.

The participants was included in the study titled 'Investigation of the Effects of the Synchronized Telerehabilitation-based Upper Extremity Training Program on Hand-arm Function, Pain, Fatigue, Quality of Life, and Participation in People With Multiple Sclerosis (ClinicalTrials.gov Identifier: NCT05073731)' will be included in this study. Questionnaires that will enable individuals to evaluate their telerehabilitation service will be administered once. Physicians and physiotherapists will make evaluations.

Registry
clinicaltrials.gov
Start Date
October 1, 2022
End Date
November 1, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Serkan Ozakbas

MD

Dokuz Eylul University

Eligibility Criteria

Inclusion Criteria

  • Having a definitive diagnosis of MS according to the 2017 McDonald criteria
  • Being over 18 years old
  • Volunteering to participate in the study
  • To have received exercise training based on synchronous or asynchronous telerehabilitation

Exclusion Criteria

  • Having a neurological disease other than MS
  • Having an MS attack 30 days before or during the study
  • Cognitive disability at a level that hinders assessment and treatment.

Outcomes

Primary Outcomes

Telehealth Usability Questionnaire

Time Frame: Baseline

Telehealth Usability Questionnaire was developed by Bakken et al. in 2006. The 21-item questionnaire evaluated the satisfaction and usability of people receiving telemedicine services. A 5-item Likert scale is used in the evaluation. The total score ranges from 21 to 105. Turkish validity and reliability were established.

Telemedicine Satisfaction Questionnaire

Time Frame: Baseline

Demiris et al. Developed by It consist of 17 items in total. A 5-item Likert-type scale is used to evaluate telemedicine service, expectation, satisfaction, and usability of people. The total score is scored between 17 and 85. Turkish validity and reliability were established.

Secondary Outcomes

  • Expanded Disability Status Scale(Baseline)

Study Sites (1)

Loading locations...

Similar Trials